Related Experiment Video
Updated: Sep 19, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
The eight pillars of within-host tuberculosis modelling
Roselyn F Kaondera-Shava1, Christian T Michael2, Denise Kirschner2
1Centre for Mathematical Biology, Department of Mathematical Sciences, University of Bath, Bath, United Kingdom.
Abstract:
Tuberculosis (TB) remains a global health challenge, driven by multiscale pathogenesis across molecular, cellular, tissue, and systemic levels. Within-host mathematical modelling provides a powerful way to explore these processes, providing mechanistic insights that are difficult to capture experimentally, including host-pathogen interactions, immune regulation, and treatment efficacy. This review synthesises the evolution of TB models from early ordinary differential equation systems to agent-based and hybrid multiscale approaches, leading to integrated pharmacokinetic/pharmacodynamic and systems pharmacology frameworks. We highlight advances in omics-driven personalisation, virtual clinical trials for regimen optimisation, multiscale and multicompartment extensions, translational impact, evolutionary dynamics, and efforts to improve reproducibility. We also examine modelling strategies for TB coinfections and comorbidities, including HIV and diabetes, which reshape granuloma biology and drug exposure. Unlike previous reviews, we integrate historical and recent within-host tuberculosis modelling advances and present quantitative visual summaries in the form of theme-by-approach heatmaps. In this work, we identify emerging opportunities and current gaps in the landscape of TB models. In addition, we develop a unique workflow for this review that can be adapted for other modelling topics. Our synthesis provides a roadmap towards computational models that may support future precision therapy and TB control strategies.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: